Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Capital Leases: 2019-2021

Historic Capital Leases for Agios Pharmaceuticals (AGIO) over the last 3 years, with Dec 2021 value amounting to $276,000.

  • Agios Pharmaceuticals' Capital Leases rose 11.29% to $276,000 in Q1 2022 from the same period last year, while for Mar 2022 it was $276,000, marking a year-over-year increase of 11.29%. This contributed to the annual value of $276,000 for FY2021, which is 16.62% down from last year.
  • Agios Pharmaceuticals' Capital Leases amounted to $276,000 in FY2021, which was down 16.62% from $331,000 recorded in FY2020.
  • Agios Pharmaceuticals' Capital Leases' 5-year high stood at $673,000 during FY2019, with a 5-year trough of $276,000 in FY2021.
  • For the 3-year period, Agios Pharmaceuticals' Capital Leases averaged around $426,667, with its median value being $331,000 (2020).
  • Data for Agios Pharmaceuticals' Capital Leases shows a maximum YoY slumped of 50.82% (in 2020) over the last 5 years.
  • Yearly analysis of 3 years shows Agios Pharmaceuticals' Capital Leases stood at $673,000 in 2019, then crashed by 50.82% to $331,000 in 2020, then dropped by 16.62% to $276,000 in 2021.